DUBLIN, Aug. 11, 2015 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that Rajiv De Silva, President and CEO, will present a corporate overview at the Canaccord Genuity 35th Annual Growth Conference in Boston on Thursday, August 13, 2015 at 3:00 p.m. ET. 

A live webcast and audio archive for the event will be available on the Company's website at www.endo.com. Click on Investor Relations, and then the link to the event. Participants should allow approximately 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo International plc

Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-announces-appearance-at-canaccord-genuity-35th-annual-growth-conference-300127027.html

SOURCE Endo International plc

Investors/Media: Keri P. Mattox, (484) 216-7912; Investors: Jonathan Neely, (484) 216-6645; Media: Heather Zoumas-Lubeski, (484) 216-6829